GI
BVS icon

GAMMA Investing’s Bioventus BVS Stock Holding History

GAMMA Investing’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.6K Buy
3,133
+74
+2% +$707 ﹤0.01% 2624
2026
Q1 		$27.9K Buy
3,059
+1,105
+57% +$9.27K ﹤0.01% 2534
2025
Q4 		$14.5K Buy
1,954
+693
+55% +$4.98K ﹤0.01% 2789
2025
Q3 		$8.44K Buy
1,261
+807
+178% +$5.6K ﹤0.01% 2962
2025
Q2 		$3K Sell
454
-179
-28% -$1.27K ﹤0.01% 3284
2025
Q1 		$5.79K Buy
633
+459
+264% +$4.58K ﹤0.01% 3026
2024
Q4 		$1.83K Buy
174
+104
+149% +$1.23K ﹤0.01% 3246
2024
Q3 		$837 Buy
+70
New +$605 ﹤0.01% 3299

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GAMMA Investing's BVS Position: Q2 2026 in Review

GAMMA Investing increased its Bioventus (BVS) stake by 2.4% in Q2 2026, buying an estimated $707 and bringing the position to 3,133 shares worth $29.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2624.

GAMMA Investing first reported a position in BVS in Q3 2024 and has held it in 8 quarters since. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • GAMMA Investing held 3,133 shares of Bioventus worth $29.6K as of Q2 2026.
  • GAMMA Investing bought 74 Bioventus shares in Q2 2026, an estimated $707.
  • Bioventus made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2624 holding.
  • GAMMA Investing first reported a position in Bioventus in Q3 2024 and has held it in 8 quarters since.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.